• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

HKCI:IN

694.75 INR 5.70 0.83%

As of 11:00:20 ET on 10/23/2014.

Snapshot for Hikal Ltd (HKCI)

Open: 695.00 Day's Range: 690.00 - 698.95 Volume: 484
Previous Close: 689.05 52wk Range: 427.20 - 780.00 1-Yr Rtn: +59.19%

Stock Chart for HKCI

No chart data available.
  • HKCI:IN 687.05
  • 1D
  • 1M
  • 1Y
689.05
Interactive HKCI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKCI

Current P/E Ratio (ttm) 17.8737
Estimated P/E(03/2015) -
Relative P/E vs. SENSEX 0.9664
Earnings Per Share (INR) (ttm) 38.8700
Est. EPS (INR) (03/2015) -
Est. PEG Ratio -
Market Cap (M INR) 11,421.76
Shares Outstanding (M) 16.44
30 Day Average Volume 28,288
Price/Book (mrq) 2.2630
Price/Sale (ttm) 1.3774
Dividend Indicated Gross Yield 0.36%
Cash Dividend (INR) 2.5000
Dividend Ex-Date 08/14/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKCI

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for HKCI

Hikal Limited specializes in the custom synthesis and contract manufacture of pharmaceuticals, agrochemicals and intermediates. The Group has relationships with a number of companies, including the Sumitomo Corporation, AgrEvo, Merck and Novartis.

Jai V HiremathChairman/Mng Dir/FounderSameer HiremathPresident/Joint Mng Dir
Peter NightingalePresident:R&DSham V WahalekarSenior VP:Finance/Secretary
More Company Profile & Key Executives for HKCI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil